Wednesday November 25 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

HERMES Biosciences

HERMES Biosciences, Inc. was founded in 1998 to develop highly innovative targeted drug delivery technologies for therapeutic and other biomedical applications. The HERMES vision builds upon previous accomplishments by HERMES scientists and others in the development of both liposomes and antibodies as targeting agents. Liposomes have become an important drug delivery system, with several first- and second-generation products approved for clinical use in oncology and infectious disease. Monoclonal antibodies have similarly become an important form of treatment, including a number of clinically useful antibodies for cancer and other diseases. Previously, HERMES founders were involved in the successful commercial development of both liposome and monoclonal antibody drugs. Now, HERMES scientists are focused on developing the next generation of targeted agents featuring full integration of the complementary technologies of liposomes and monoclonal antibodies. This has resulted in the development of modularly assembled and molecularly targeted carrier systems. These novel agents are capable of delivering an array of small molecule drugs and probes, macromolecular agents, and nucleic acid therapeutics specifically to target cells. This represents a promising new approach for the diagnosis and treatment of cancer and other important diseases.


Contact Details:
61 Airport Blvd., Suite B
South San Francisco
California
94080.
United States of America
Tel:(650) 873-2583
Fax:(650) 873-2501
Email:
WWW:

www.hermesbio.com/




Loading...

Recent Publications by HERMES Biosciences:

Development of a highly stable and targetable nanoliposomal formulation of topotecan.
Topotecan (TPT), a highly active anticancer camptothecin drug, would...
19th August, 2009
Hermes Biosciences, Inc., 61 Airport Boulevard, Suite D, South San J Control Release. 2009 Aug 15.
DOI Direct Link
Characterization of highly stable liposomal and immunoliposomal formulations of vincristine and vinblastine.
PURPOSE: Liposome and immunoliposome formulations of two vinca alkaloids,...
18th August, 2009
Hermes Biosciences Inc, South San Francisco, CA 94080, USA. Cancer Chemother Pharmacol. 2009 Sep;64(4):741-51. Epub 2009 Jan 30.
DOI Direct Link
Improved pharmacokinetics and efficacy of a highly stable nanoliposomal vinorelbine.
Effective liposomal formulations of vinorelbine (5'...
4th February, 2009
Hermes Biosciences, Inc., 61 Airport Blvd., Suite D, South San Francisco, J Pharmacol Exp Ther. 2009 Jan;328(1):321-30. Epub 2008 Oct 23.
DOI Direct Link
Pharmacokinetics and in vivo drug release rates in liposomal nanocarrier development.
Liposomes represent a widely varied and malleable class of drug carriers...
31st January, 2009
Hermes Biosciences, Inc., South San Francisco, California 94080, USA. J Pharm Sci. 2008 Nov;97(11):4696-740.
DOI Direct Link
Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models.
We describe evidence for a novel mechanism of monoclonal antibody...
8th September, 2006
Hermes Biosciences Inc., South San Francisco, CA, USA. Cancer Res. 2006 Jul 1;66(13):6732-40.
DOI Direct Link

View more HERMES Biosciences research publications.

Press Releases on HERMES Biosciences:

BioPortfolio Logo
Reportlinker Adds Monoclonal Antibodies: Pipeline Analysis and Competitive Assessment 26th October, 2009 Reportlinker
-- A focus on "engineered" antibodies Monoclonal Antibodies: Pipeline Analysis and Competitive Assessment reviews the broad drug development effort that is focused on bringing

BioNews Results for HERMES Biosciences:

MedMira Rapid HIV Test Now Classified as Medical Device in China, Increasing Revenue and Sales Opportunities
Stockwatch:  Sep 24 2009 2:04PM Matching: hermes biosciences

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 558 times since April 2007, the link to the organisation's website has been followed 93 times

Recent Search Terms used to find this page: hermes biosciences | hermes disease | hermes biosciences | what did hermes accomplish | Hermes accomplishments | accomplishments of hermes | hermes biosciences | hermes accomplishments | hermes accomplishments | hermes accomplishments | .

Search for more companies in South San Francisco

Search for more companies in California



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for HERMES Biosciences

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.